CNBP (aka DM2, ZNF9) Gene Curation
Gene-disease assertions not curated here (add link or write note):
Disease | CNBP-related myotonic dystrophy aka myotonic dystrophy type 2 |
---|---|
Inheritance | Autosomal dominant |
Prevalence | 1-9 / 100 000 Source:ORPHA:606 |
Rapid or full curation? | Rapid Full |
ClinGen - none. GenCC - Strong (Invitae), BabySeq - none. HGMD - 1 entry for repeat expansions. | |
Clinical Validity Scoring Notes and points | Liquori 2001 (PMID: 11486088) - mapped the MD2 locus and used positional cloning to identify the DM2 mutation. Per text, all 51 affected individuals in 6 DM2 families were found to have expanded alleles (confirmed by Southern and PCR, counting max 3 POINT SEGREGATION) Sequencing revealed a complex repeat motif ( TG)n( TCTG)n(CCTG)n. In controls this tract ranged from 104-176 basepairs. The largest repeat tract in normal controls had 26 CCTG repeats with two interruptions. Three families with a total of 6 individuals with expansions of the CCTG repeat (fig 1D), 3 segregations. Expanded alleles ranged from 75-1100 CCTG repeats (6 families with expansions, 1 proband each family 0.5x6 variant points, 3 VARIANT POINTS). Bachinski 2003 (PMID: 12970845) - 17 kindreds of European origins link to the locus. Fig 2 shows a family with expansion found in RP-PCR. Counting segs based on RP-PCR results: III:2 proband, segregations in III:3, III:4, IV:2, II:1 (obligate), II:3, II:6. Total of 6 segs. Per the text, linkage was done for 17 families with DM2. The expansion was present in the kindreds as confirmed by Southern. (17x0.5 = 8.5 variant points) Nakayama 2014 (PMID: 24430576) - family with DM2, proband found to have 3400 CCTG repeats. Repetition over time. Wei 2018 PMID:29735719. Immunofluorescence of muscle from DM2 patients and controls found that CNBP localized in cytoplasm in control tissue whereas it localized primarily ni membrane of DM2 fibers. Animal model - CNBP knockout mouse had muscle atrophy at young age, heterozygous mice had severe muscle loss only at advanced age. Since the KO mice aren’t true replications of the expanded allele, not scoring. Functional alteration in patient cells - 1 POINT EXPERIMENTAL Raheem 2010 PMID: 20971734 - In differentiating myoblasts, in patients with DM2, ZNF9 was abnormally expressed. There was overall reduction in mRNA and protein levels. The subcellular localization was more membrane bound. Splice variant analysis indicated retention of intron 3. Functional alteration in non-patient cells 0.5 points experimental. 12 points genetic (max allowed) + 1.5 points experimental |
Clinical Validity Points Total | 13.5 points |
Clinical Validity Classification Definitive (12pts) Strong (12pts) Moderate (7-11pts) Limited (0.1-6pts) No genetic evidence Refuted Disputed | Definitive Source: 11486088, 12970845, 29735719, 20971734 |
Molecular Mechanism Loss of function Gain of function Dominant negative Unknown Other | Short tandem repeats ONLY (no other variant type reported) STR expansion - complex motif (TG)n(TCTG)n(CCTG)n . Other labs report by the basepair size; however, we will get CCTG repeat size. It is the expansion of this tract that has been associated with disease.
Literature:
|
Penetrance Complete (100%) High (≥80%) Moderate (<80% and >20%) Low (≤20%) (list source/PMID) | Moderate / Low Source: 11486088 |
Age of Onset Congenital Pediatric Adolescent Adulthood Late adulthood (list source/PMID) | Adulthood, late adulthood |
Severity | Moderate |
Clinical Features | myotonia and muscle dysfunction (proximal and axial weakness, myalgia, and stiffness) cataracts cardiac conduction defects insulin-insensitive type 2 diabetes mellitus Sources: PMID: 20301639 |
HPO Terms |
|
Gene SOPs & Notes | short tandem repeat expansions are the only known variant associated with disease, see mol. mech section |
Curation Summary | The CNBP gene is associated with autosomal dominant myotonic dystrophy type 2, which is characterized by myotonia and muscle dysfunction, cataracts, cardiac conduction defects, and type 2 diabetes. It is caused by a short tandem repeat expansion. Age of onset is in adulthood, severity can vary, and reduced penetrance has been observed (PMID: 20301639, 11486088) |
Case ID, Curator name, Date, Jira ticket link | Andrea Oza 09.29.2023 https://broadinstitute.atlassian.net/browse/BCL-168 |